February 4th marks World Cancer Day, a day of global observance and, most importantly, a golden opportunity to raise awareness of this deadly and multifaceted disease. Every year, various types of cancer are responsible for causing millions of deaths irrespective of race, age or gender.
The fight against cancer is not a battle that should begin with a diagnosis. Your daily lifestyle and awareness of this disease will give you a significant advantage in cancer prevention or early detection, which is crucial in overcoming it.
There are several proactive steps one can undertake to reduce the likelihood of developing cancer.
- Quit Smoking – Tobacco smoke contains toxins that can potentially harm or alter the DNA within a cell, increasing cancer development considerably. Tobacco also weakens the immune system, making it much harder for the body to fight off cancerous cells.
- Reduce Sun Exposure – Exposure to the sun’s damaging ultraviolet (UV) rays can elevate the risk of developing skin cancer.
- Embrace a Healthy Lifestyle – Maintain a routine that includes physical activity and a nutritious diet. Regular exercise is associated with a reduced risk of cancer. Opt for a diet rich in fruits, vegetables, whole grains and lean proteins.
- Routine Cancer Screenings – Routine cancer screenings are vital for identifying abnormal cells early on. Early detection is key in saving lives. Consult your doctor to determine the most suitable screenings for you, taking into account your specific risk factors.
- HPV Vaccinations – Individuals between the ages of 9 and 26 are recommended to get the HPV vaccine as it helps to prevent HPV infection, which is the primary cause of cervical cancer, as well as oral, anal and genital cancer.
Cancer Treatment at Sheba
Sheba’s Jusidman Cancer Center, led by Prof. Raanan Berger, stands as Israel’s foremost facility for cancer care. Annually, it welcomes 4500 new patients, providing comprehensive treatments, clinical follow-ups and diagnostic tests to thousands of individuals battling cancer.
Furthermore, Sheba boasts a distinguished oncology department. Specializing in advanced treatments like CAR-T, TIL and bone marrow transplantation, Sheba provides a wide range of options for cancer care. The center’s team comprises some of the world’s most experienced and esteemed specialists, bringing years of expertise to the forefront of cancer treatment.
Hemato-Oncology – Leukemia (ALL/AML)
The Hemato-Oncology Division at Sheba specializes in advanced, personalized treatments for adult acute lymphoblastic leukemia (ALL). Under the leadership of world-renowned experts, our team of medical professionals employ an integrated approach involving medical oncologists, radiation oncologists and hematologists.
Pioneering in innovative therapies such as CAR T-cell therapy and advanced bone marrow transplants, Sheba leverages state-of-the-art laboratories for precise donor matching, with access to international donor programs. Emphasizing holistic care, the center focuses on the physical, psychological and overall well being of patients, ensuring they are active participants in their treatment journey. This patient-centered approach extends beyond medical treatment, offering comprehensive support to enhance the quality of life for patients and their families.
Hemato-Oncology – Multiple Myeloma
Multiple myeloma, alternatively termed plasma cell myeloma, represents a rare form of cancer that arises from plasma cells, which are crucial for antibody production in the immune system.
This disease occurs when these plasma cells in the bone marrow undergo malignant transformation and proliferate excessively. As a consequence, these cells produce abnormal antibodies known as M proteins or paraproteins, potentially causing a range of health complications.
Managing multiple myeloma requires a strong partnership with healthcare providers, comprehension and adherence to treatment regimens, and vigilant pain and symptom control. Emotional support, whether through professional counseling or support groups, plays a significant role in navigating the patient’s journey. Maintaining a healthy lifestyle through balanced nutrition and physical activity, coupled with close monitoring of any health changes, is crucial.
Adherence to prescribed medications, focusing on enhancing life quality through enjoyable activities, considering advance care planning, and staying updated on the latest research and treatments are all essential elements of effectively living with multiple myeloma.
While representing less than one percent of skin cancer cases, melanoma stands out as the most aggressive, accounting for around 80% of skin cancer deaths. Originating in melanocytes, the pigment-producing cells in the skin, it can develop in any area of the skin. Each year, about 1,800 individuals are diagnosed with melanoma in Israel. Early detection, especially when the cancer is still localized, typically allows for highly successful treatment outcomes.
Sheba is proud to offer the most cutting-edge melanoma treatments available, including sophisticated immunotherapy methods, and giving patients access to participate in current clinical trials.
The Ella Lemelbaum Institute for Immuno-Oncology at Sheba is committed to providing premier melanoma care and ongoing research into this prevalent disease. Our elite team, comprising skilled clinicians, researchers and nursing staff, is dedicated to delivering comprehensive integrative care to patients and their families. Collaborating with leading global melanoma treatment institutions, including the U.S. National Institutes of Health (NIH), the Ella Institute exemplifies excellence in melanoma treatment and research.
Prostate cancer ranks as one of the most prevalent types of cancer in men. There are a variety of treatment options including surgery, chemotherapy, hormone therapy, radiation therapy, robotic surgery, lutetium-177 PSMA therapy and NanoKnife.
Adenocarcinomas constitute the majority of prostate cancer cases, although other forms like sarcomas and small cell carcinomas are also seen. It’s important to note that while prostate enlargement and inflammation are common in men, these conditions don’t necessarily indicate cancer. Nonetheless, it’s crucial to thoroughly examine any such symptoms to exclude the possibility of cancer.
Unlike most developed countries, Sheba utilizes 68Ga-PSMA and has successfully conducted over 450 scans using this technology in the last several years. This extensive experience has endowed our team with invaluable expertise in the procedure, enabling us to confidently offer it to our patients when it’s deemed suitable.
In conclusion, Sheba Medical Center remains at the forefront of cancer care and research, offering a beacon of hope and advanced treatment options to those affected by this challenging disease, reaffirming our unwavering commitment to saving lives and enhancing patient care.